276 related articles for article (PubMed ID: 38179656)
1. An overview of chemically induced rodent models for sporadic colorectal cancer: Histopathological and translational perspectives.
Sarmiento-Machado LM; Rodrigues MAM; Romualdo GR; Barbisan LF
Histol Histopathol; 2024 Jun; 39(6):691-702. PubMed ID: 38179656
[TBL] [Abstract][Full Text] [Related]
2. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling.
Romualdo GR; Leroy K; Costa CJS; Prata GB; Vanderborght B; da Silva TC; Barbisan LF; Andraus W; Devisscher L; Câmara NOS; Vinken M; Cogliati B
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771745
[TBL] [Abstract][Full Text] [Related]
3. Mouse models of colorectal cancer: Past, present and future perspectives.
Bürtin F; Mullins CS; Linnebacher M
World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
[TBL] [Abstract][Full Text] [Related]
4. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
Jass JR
Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
[TBL] [Abstract][Full Text] [Related]
5. From mice to men: Murine models of colorectal cancer for use in translational research.
Evans JP; Sutton PA; Winiarski BK; Fenwick SW; Malik HZ; Vimalachandran D; Tweedle EM; Costello E; Palmer DH; Park BK; Kitteringham NR
Crit Rev Oncol Hematol; 2016 Feb; 98():94-105. PubMed ID: 26558688
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.
Mármol I; Sánchez-de-Diego C; Pradilla Dieste A; Cerrada E; Rodriguez Yoldi MJ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106826
[TBL] [Abstract][Full Text] [Related]
7. Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks.
Romualdo GR; Heidor R; Bacil GP; Moreno FS; Barbisan LF
Life Sci; 2023 Oct; 330():121994. PubMed ID: 37543357
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenograft model in colorectal cancer basic and translational research.
Liu X; Xin Z; Wang K
Animal Model Exp Med; 2023 Feb; 6(1):26-40. PubMed ID: 36543756
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review).
Ahmad R; Singh JK; Wunnava A; Al-Obeed O; Abdulla M; Srivastava SK
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33655327
[TBL] [Abstract][Full Text] [Related]
10. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies.
Keum N; Giovannucci E
Nat Rev Gastroenterol Hepatol; 2019 Dec; 16(12):713-732. PubMed ID: 31455888
[TBL] [Abstract][Full Text] [Related]
11. Colorectal carcinogenesis--update and perspectives.
Raskov H; Pommergaard HC; Burcharth J; Rosenberg J
World J Gastroenterol; 2014 Dec; 20(48):18151-64. PubMed ID: 25561783
[TBL] [Abstract][Full Text] [Related]
12. [Mouse models for human colorectal cancer with liver metastasis].
Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
[No Abstract] [Full Text] [Related]
13. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract][Full Text] [Related]
14. Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease.
Belmont PJ; Budinska E; Jiang P; Sinnamon MJ; Coffee E; Roper J; Xie T; Rejto PA; Derkits S; Sansom OJ; Delorenzi M; Tejpar S; Hung KE; Martin ES
Dis Model Mech; 2014 Jun; 7(6):613-23. PubMed ID: 24742783
[TBL] [Abstract][Full Text] [Related]
15. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
Koelink PJ; Robanus-Maandag EC; Devilee P; Hommes DW; Lamers CB; Verspaget HW
Carcinogenesis; 2009 Jul; 30(7):1217-24. PubMed ID: 19420017
[TBL] [Abstract][Full Text] [Related]
17. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
[TBL] [Abstract][Full Text] [Related]
18. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
Bui VM; Mettling C; Jou J; Sun HS
BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
[TBL] [Abstract][Full Text] [Related]
19. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
20. Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer.
Dzhalilova D; Zolotova N; Fokichev N; Makarova O
PeerJ; 2023; 11():e16159. PubMed ID: 37927787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
